UCA1 and acute myeloid leukemia: At the same time, lncRNA UCA1 was significantly highly expressed in the AML patient group, which is consistent with our transcriptome sequencing results, demonstrating that these two key genes may serve as potential biological markers of diagnostic, targeted therapeutic (Figure 13).